Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12351
CALL
iHeartMedia
IHRT
$457M
| $30.3K | ﹤0.01% |
+16,400
| New | +$24.4K |
|
|
INZY
12352
PUT
DELISTED
Inozyme Pharma
INZY
| $30.3K | ﹤0.01% |
5,800
+3,100
| +115% | +$16.1K |
|
|
LONA
12353
PUT
LeonaBio Inc
LONA
$74.8M
| $30.3K | ﹤0.01% |
6,800
+5,510
| +427% | +$129K |
|
12354
ClearOne Inc
CLRO
$14M
| $30.3K | ﹤0.01% |
3,265
+2,370
| +265% | +$22.5K |
|
12355
PUT
Karyopharm Therapeutics
KPTI
$45.8M
| $30.3K | ﹤0.01% |
2,433
+786
| +48% | +$9.77K |
|
|
SATX
12356
DELISTED
SatixFy Communications
SATX
| $30.3K | ﹤0.01% |
+42,839
| New | +$29.5K |
|
12357
Bain Capital Specialty
BCSF
$814M
| $30.3K | ﹤0.01% |
1,824
-82,068
| -98% | -$1.36M |
|
12358
CALL
Compañía de Cervecerías Unidas
CCU
$2.18B
| $30.2K | ﹤0.01% |
+2,600
| New | +$29.1K |
|
12359
CALL
ThredUp
TDUP
$403M
| $30.2K | ﹤0.01% |
35,900
+30,800
| +604% | +$37.6K |
|
|
CLPR
12360
CALL
Clipper Realty
CLPR
$54M
| $30.2K | ﹤0.01% |
5,300
-14,000
| -73% | -$62.7K |
|
12361
Northann Corp
NCL
| $30.2K | ﹤0.01% |
20,970
+15,461
| +281% | +$26K |
|
|
GP
12362
CALL
GreenPower Motor Co
GP
$13M
| $30.1K | ﹤0.01% |
2,200
+1,530
| +228% | +$16.7K |
|
12363
PUT
Jasper Therapeutics
JSPR
$26.3M
| $30.1K | ﹤0.01% |
+1,600
| New | +$31.9K |
|
12364
Aurora
AUR
$13.7B
| $30.1K | ﹤0.01% |
5,076
-1,356,848
| -100% | -$5.65M |
|
12365
CALL
Aegon
AEG
$14B
| $30K | ﹤0.01% |
4,700
-2,600
| -36% | -$16.1K |
|
12366
CALL
Cato Corp
CATO
$67.9M
| $29.9K | ﹤0.01% |
6,000
-200
| -3% | -$985 |
|
|
NAGE
12367
PUT
Niagen Bioscience
NAGE
$239M
| $29.9K | ﹤0.01% |
8,200
+2,100
| +34% | +$6.61K |
|
|
NOA
12368
PUT
North American Construction
NOA
$375M
| $29.9K | ﹤0.01% |
1,600
-6,000
| -79% | -$113K |
|
12369
CALL
Epsilon Energy
EPSN
$169M
| $29.9K | ﹤0.01% |
+5,100
| New | +$27.3K |
|
12370
CALL
MoneyHero
MNY
$40.1M
| $29.9K | ﹤0.01% |
27,400
+17,200
| +169% | +$23.9K |
|
|
STLN
12371
Starling Oncology
STLN
$657M
| $29.9K | ﹤0.01% |
91,337
-178,367
| -66% | -$73.9K |
|
12372
XBP Global Holdings
XBP
$33.1M
| $29.8K | ﹤0.01% |
+2,789
| New | +$36.2K |
|
12373
CALL
Lexicon Pharmaceuticals
LXRX
$1.03B
| $29.8K | ﹤0.01% |
19,000
-23,700
| -56% | -$42.2K |
|
12374
CALL
Fuel Tech
FTEK
$45.3M
| $29.8K | ﹤0.01% |
28,400
+28,200
| +14,100% | +$28.9K |
|
|
ENZ
12375
DELISTED
Enzo Biochem, Inc.
ENZ
| $29.8K | ﹤0.01% |
+26,594
| New | +$29.8K |
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,614 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.